Lazard Asset Management LLC Novavax Inc Transaction History
Lazard Asset Management LLC
- $61.8 Billion
- Q4 2024
A detailed history of Lazard Asset Management LLC transactions in Novavax Inc stock. As of the latest transaction made, Lazard Asset Management LLC holds 4,934 shares of NVAX stock, worth $39,422. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,934
Previous 8,652
42.97%
Holding current value
$39,422
Previous $109,000
64.22%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding NVAX
# of Institutions
285Shares Held
93.8MCall Options Held
5.4MPut Options Held
8.76M-
Vanguard Group Inc Valley Forge, PA15.7MShares$126 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$94.7 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$89.1 Million35.54% of portfolio
-
State Street Corp Boston, MA7.7MShares$61.5 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.79MShares$46.3 Million0.04% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $625M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...